Molecular Cancer Therapeutics

290.0k citations
6.8k papers · · active since 1950

Impact in

  • Oncology top 1%
    • Cancer-related Molecular Pathways
    • HER2/EGFR in Cancer Research
    • Cancer, Hypoxia, and Metabolism

Papers in

    • Cancer-related Molecular Pathways 645
    • HER2/EGFR in Cancer Research 444
    • Cancer, Hypoxia, and Metabolism 487

Molecular Cancer Therapeutics

6.5k papers receiving 283.4k citations

Peers

Molecular Cancer Therapeutics
Comparison fields: 5 of 215
  • Oncology 88.5k
  • Cancer Research 47.2k
  • Molecular Biology 156.1k
  • Immunology 26.6k
  • Toxicology 4.2k
Replace International Journal of Oncology with:
International Journal of Oncology United States
Nature Reviews Drug Discovery United States
Oncology Reports China
BMC Cancer China
Frontiers in Pharmacology China
Journal of Cellular Biochemistry United States
Biomedicine & Pharmacotherapy China
Clinica Chimica Acta United States
Frontiers in Oncology China
Pharmacology & Therapeutics United States
Molecular Cancer Therapeutics relative to International Journal of Oncology United States International Journal of Oncology's profile →
Citations per field
00.5×1.5×1.9×
International Journal of Oncology · 1×
Citations per year

Countries where authors publish in Molecular Cancer Therapeutics

Since Specialization
Citations

This map shows the geographic impact of research published in Molecular Cancer Therapeutics. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Molecular Cancer Therapeutics with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Molecular Cancer Therapeutics more than expected).

Fields of papers published in Molecular Cancer Therapeutics

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Molecular Cancer Therapeutics. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Molecular Cancer Therapeutics.

About Molecular Cancer Therapeutics

The 6.8k papers published in Molecular Cancer Therapeutics in the last decades have received a total of 290.0k indexed citations . Papers published in Molecular Cancer Therapeutics usually cover Oncology (3.0k papers), Cancer Research (1.3k papers), Molecular Biology (4.1k papers), Pulmonary and Respiratory Medicine (1.1k papers) and Genetics (366 papers) specifically the topics of Cancer-related Molecular Pathways (645 papers), Cancer, Hypoxia, and Metabolism (487 papers), PI3K/AKT/mTOR signaling in cancer (470 papers), Monoclonal and Polyclonal Antibodies Research (469 papers), HER2/EGFR in Cancer Research (444 papers), Lung Cancer Treatments and Mutations (400 papers), Cell death mechanisms and regulation (377 papers) and Ubiquitin and proteasome pathways (371 papers). The most active scholars publishing in Molecular Cancer Therapeutics are Razelle Kurzrock, Sandip Pravin Patel, Edith A. Perez, Daniel D. Von Hoff, Garth Powis, Frank A. Sinicrope, Takumi Kawabe, Yves Pommier, Santosh K. Katiyar and Shengbing Huang.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact